Colloidal Silicic Acid for the Treatment of Psoriatic Skin Lesions,Arthropathy and Onychopathy. A Pilot Study

Abstract

In a randomized, double-blind study, patients with chronic plaque-type psoriasis were either treated with 30 ml colloidal silicic acid gel, orally, daily, and topically with the same gel (n = 15), or were treated identically with placebo gel (n = 15) for 3 months. One stable psoriatic lesion on the knee or elbow was treated topically and followed throughout the study. Five patients in the treated group and seven controls had psoriatic arthropathy and 11 treated patients and 12 controls had psoriatic onychopathy. Three treated patients and six controls withdrew because of skin irritation or lack of efficacy. In the treated group there were clear improvements in scaling, induration and erythema after treatment. The nail changes were cured in five of 10 evaluable patients in the treated group and joint pain was reduced by almost half in the four evaluable patients with arthropathy. There were no such improvements in the placebo group.

Keywords

Silicic acid Psoriasis Psoriatic arthropathy Psoriatic onychopathy

Get full access to this article

View all access options for this article.

References

Fregert

: Studies on silicon in tissues with special reference to skin. J Invest Dermatol 1958; 31: 95–96.

Fregert

: Studies on silicon in tissues with special reference to skin. Acta Derm Venereol Suppl (Stockh) 1959; 42: 1–92.

Lassus

: Colloidal silicic acid for oral and topical treatment of aged skin, fragile hair and brittle nails in females. J Int Med Res 1993; 21: 209–215.

Berglund

Johansson

B-G

Nived

: Inflammatory parameters in rheumatoid arthritis during and after administration of an antimitotic agent (podophyllom lignan derivatives). Scand J Rheumatol 1975; 7: 61–63.